Abstract: The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
| # | Name | Date |
|---|---|---|
| 1 | 202417039977-STATEMENT OF UNDERTAKING (FORM 3) [22-05-2024(online)].pdf | 2024-05-22 |
| 3 | 202417039977-Sequence Listing in PDF [22-05-2024(online)].pdf | 2024-05-22 |
| 4 | 202417039977-REQUEST FOR EXAMINATION (FORM-18) [22-05-2024(online)].pdf | 2024-05-22 |
| 5 | 202417039977-POWER OF AUTHORITY [22-05-2024(online)].pdf | 2024-05-22 |
| 6 | 202417039977-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [22-05-2024(online)].pdf | 2024-05-22 |
| 7 | 202417039977-FORM 18 [22-05-2024(online)].pdf | 2024-05-22 |
| 8 | 202417039977-FORM 1 [22-05-2024(online)].pdf | 2024-05-22 |
| 9 | 202417039977-DRAWINGS [22-05-2024(online)].pdf | 2024-05-22 |
| 10 | 202417039977-DECLARATION OF INVENTORSHIP (FORM 5) [22-05-2024(online)].pdf | 2024-05-22 |
| 11 | 202417039977-COMPLETE SPECIFICATION [22-05-2024(online)].pdf | 2024-05-22 |
| 12 | 202417039977-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [22-05-2024(online)].pdf | 2024-05-22 |
| 13 | 202417039977-FORM-26 [23-05-2024(online)].pdf | 2024-05-23 |
| 14 | 202417039977-Proof of Right [18-06-2024(online)].pdf | 2024-06-18 |
| 15 | 202417039977-FORM 3 [06-11-2024(online)].pdf | 2024-11-06 |